When Is Glaucoma Surgery Needed? What Pushes Care Beyond Drops and Laser

The appointment is running long. A woman in her sixties sits across from her ophthalmologist, a folder of visual field printouts between them, each one a little grayer at the edges than the last. She has used her drops every night for seven years. She had the laser treatment two winters ago. And still the doctor is saying the word she has been dreading: surgery.

She is not alone in asking the question that brought you here. When is glaucoma surgery needed, and what makes a doctor decide that drops and laser are no longer enough? The answer is rarely a single dramatic moment. It is more often a slow accumulation of evidence: pressure readings that will not settle, nerve scans that keep thinning, a life that does not fit around four bottles of drops.

This explainer walks through that evidence the way a glaucoma specialist weighs it, so the conversation in that exam room feels less like a verdict and more like a shared decision.

When is glaucoma surgery needed? The short version

Glaucoma is a group of conditions in which the optic nerve, the cable that carries images from the eye to the brain, is slowly damaged, most often because fluid pressure inside the eye is higher than that nerve can tolerate. Nearly every treatment, from drops to laser to surgery, works by lowering that pressure. The question is not whether to lower it, but how far and by what means.

Surgery moves to the top of the list in a handful of recognizable situations. The first is pressure that stays above the individual target despite drops and laser. The second is progression: the nerve or the visual field keeps deteriorating even though the pressure numbers look tidy, which tells the team the target itself was set too high for that eye. The third is intolerance, when drops cause redness, allergy or breathing effects, or when a person simply cannot manage them because of arthritis, memory problems or a life that makes a strict nightly routine unrealistic. The fourth is urgency, such as an angle-closure attack where pressure spikes suddenly and drops alone cannot keep it down.

The NHS describes surgery as an option when drops and laser have not lowered the pressure enough, and the Mayo Clinic frames surgery and laser as choices made when medicines are not working or are not tolerated. Neither source describes a fixed pressure number or a set number of failed drops that triggers an operation. That absence is deliberate. A person with mild damage and a healthy fellow eye can afford to wait and watch; a person with advanced loss in their only good eye cannot. The same pressure reading means very different things in those two charts.

Why eye pressure matters so much in glaucoma

The eye makes a clear fluid called aqueous humor, which is not the same as tears. It is produced behind the iris, flows forward through the pupil, and drains out through a spongy meshwork in the angle where the iris meets the cornea. Production and drainage stay in balance in a healthy eye, and the resulting pressure, measured in millimeters of mercury, typically sits between about 10 and 21 mmHg according to the Cleveland Clinic.

Glaucoma usually develops when the drain becomes less efficient. Fluid keeps arriving, exits more slowly, and the pressure creeps up. The optic nerve fibers pass out of the back of the eye through a sieve-like structure, and sustained pressure on that sieve strangles the fibers one by one. Because the brain quietly fills in the gaps, most people notice nothing until a substantial number of fibers have gone. The CDC estimates about 3 million Americans have glaucoma and roughly half do not know it, which is why it is often called a silent disease.

Two details shape the surgical conversation. First, the damage does not reverse. The National Eye Institute is blunt that surgery can lower pressure but cannot restore vision already lost, so the goal is always to protect what remains. Second, the pressure a nerve can tolerate varies from person to person. Some people develop damage at readings within the normal range, a form often called normal-tension glaucoma; others carry higher readings for years without harm. This is why teams talk about a target pressure rather than a normal one. The target is the reading below which that particular nerve appears to stop deteriorating, and it is revised downward whenever the evidence says the nerve is still losing ground.

What drops and laser do, and where they run out of road

Most glaucoma care begins with drops, and for many people it ends there. The Mayo Clinic lists the main classes: prostaglandin analogs, which open an alternative drainage route; beta blockers, alpha agonists and carbonic anhydrase inhibitors, which reduce fluid production; and newer rho kinase inhibitors, which act on the main drain itself. Each lowers pressure by a modest amount, and combining two or three classes lowers it further. The prescribing clinician chooses and adjusts them; nothing in this article should be read as advice to change what you have been given.

Laser trabeculoplasty is the other early option. A focused beam is applied to the drainage meshwork to improve outflow. It is done in the clinic, is usually painless, and the Mayo Clinic notes it can take a few weeks to see the full effect. Some guidelines now offer it as a first treatment rather than a fallback, because it removes the daily burden of drops for as long as it keeps working.

The limits of both approaches are practical rather than theoretical. Drops only work if they go in, and studies of adherence consistently find that many people miss doses, struggle to aim the bottle, or stop because of stinging and redness. Each added bottle multiplies those problems and adds preservative exposure to the surface of the eye. Laser effects tend to fade over months to years, and repeat treatment lowers pressure less each time. When a team has stacked several classes and used laser and the pressure still sits above target, or the nerve keeps thinning regardless, the ceiling of non-surgical care has been reached. That is the practical answer to when glaucoma surgery is needed.

Five signals that push care beyond drops and laser

Ask a glaucoma specialist what actually tips the balance and the answer rarely rests on one number. It rests on patterns. These are the five that appear again and again in guideline discussions from NICE, the NHS and major eye institutes.

• Pressure that will not reach target. If the maximum tolerated combination of drops plus laser leaves the reading consistently above the individualized target, the team has no lower gear left short of surgery.
• Documented progression. Two or more reliable visual field tests or nerve fiber scans showing steady loss, even at a pressure that looked acceptable, means the target must fall further than medicines can realistically take it.
• Advanced damage at diagnosis. Someone who arrives with severe field loss has little reserve. Teams often move to surgery early because there is no margin for a slow trial of drops.
• Intolerance or inability to use drops. Allergy, surface disease, side effects, tremor, dementia/">dementia or a life that cannot accommodate the routine all count. Adherence is not a moral failing; it is a clinical variable.
• Angle-closure or secondary glaucomas. A closed drainage angle, inflammation, prior injury or abnormal blood vessel growth can each raise pressure in ways drops struggle to control, and specific procedures address the underlying anatomy.

Notice what is missing from the list: age alone, a single high reading on a stressful day, or a desire to be free of drops without any of the above. Wanting fewer bottles is a legitimate factor that shapes which operation is chosen, but by itself it seldom justifies the risks of the larger procedures. The Mayo Clinic notes that surgery does not guarantee freedom from drops afterward; some people still need them. That honesty belongs in the conversation from the start.

How do you know what stage of glaucoma you have?

People often leave clinic knowing their pressure but not their stage, and the stage is what actually drives urgency. Staging is based mainly on how much of the visual field has been lost and how the optic nerve looks, not on the pressure reading itself.

Three tests do most of the work. Visual field testing, sometimes called perimetry, maps the areas where you can and cannot see faint lights while fixing your gaze on a central point. Early glaucoma shows small blind patches away from the center; moderate disease shows arc-shaped defects on one or both sides; advanced disease has losses that approach or involve central vision. Optical coherence tomography, or OCT, is a painless scan that measures the thickness of the nerve fiber layer around the optic nerve in microns, and thinning on the scan often appears before the field test can detect it. The third is the clinical look at the optic nerve head, where the doctor judges how much of the disc has been hollowed out, described as the cup-to-disc ratio.

Doctors group the results into mild, moderate and severe, though the exact cutoffs differ between classification systems and no single one is universal. What matters more than the label is the trend. A mild stage that has been stable for five years is a calm situation. A mild stage that was normal two years ago is not. The Johns Hopkins overview stresses that regular monitoring is the only way to tell the difference, because the disease itself gives no warning.

It is entirely reasonable to ask your ophthalmologist directly: what stage am I, has it changed since my last visit, and how much reserve do I have? Those three answers explain almost every decision about when glaucoma surgery is needed for a given person.

What actually happens during glaucoma surgery

Every glaucoma operation has the same aim: create or improve a path for fluid to leave the eye so pressure falls. The approaches differ in how big the new path is and how much the surgeon can adjust it afterward.

Trabeculectomy is the long-established procedure and, according to the NHS, the most common. The surgeon makes a small trapdoor in the white wall of the eye, the sclera, under the upper eyelid, removes a tiny piece of tissue beneath it, and lets fluid seep through into a blister-like reservoir under the thin outer membrane called the conjunctiva. That reservoir, known as a bleb, slowly absorbs the fluid into surrounding vessels. Surgeons often apply a medicine during the operation to slow scarring, because the body naturally tries to seal any new opening. Stitches on the trapdoor can be loosened or removed in clinic during the following weeks to fine-tune the flow.

Tube or drainage device surgery places a small silicone tube into the front of the eye, connected to a plate positioned toward the back of the eyeball under the conjunctiva. Fluid drains along the tube to the plate, where it is absorbed. Tubes are often chosen when scarring makes a trabeculectomy less likely to keep working, or in secondary glaucomas.

Minimally invasive glaucoma surgery, usually shortened to MIGS, describes a family of procedures using microscopic stents, tiny incisions or gentle enlargement of the natural drain, most often performed through the same small opening used for cataract surgery. The National Eye Institute notes these tend to lower pressure less than trabeculectomy but carry fewer risks. Laser procedures that reduce fluid production, applied to the ciliary body behind the iris, sit at the other end of the spectrum and are typically reserved for difficult cases.

All of these are performed under local anesthetic with sedation in most adults, usually as a day procedure, with the eye numbed and the patient awake but comfortable.

MIGS, trabeculectomy or a tube: how the options compare

Choosing between procedures is a trade-off between how much pressure reduction is needed and how much risk and recovery a person can accept. The table below summarizes the broad pattern described by the National Eye Institute, the Mayo Clinic and the NHS. It is a map, not a menu; the treating team matches the operation to the eye.

Approach	What is done	Typical pressure lowering	Usually considered when	Main trade-offs
MIGS	Micro-stent or tiny incision to improve the natural drain, often combined with cataract surgery	Modest	Mild to moderate disease; wish to reduce drops; cataract already planned	Fewer early complications; may not reach a low target; some devices lack long-term data
Trabeculectomy	Surgical trapdoor creating a drainage bleb under the eyelid	Substantial and adjustable	Moderate to advanced disease; low target needed; drops and laser exhausted	More follow-up visits; bleb-related risks including infection and low pressure; scarring can close it
Tube (drainage device)	Silicone tube to a plate beneath the conjunctiva	Substantial	Prior failed surgery; heavy scarring; secondary glaucomas	Tube exposure or corneal effects over time; early pressure swings
Cyclophotocoagulation	Laser applied to the fluid-producing tissue	Variable	Advanced or refractory disease; eyes with limited visual potential	Less predictable; may need repeating; inflammation

The pattern is consistent: the procedures that lower pressure the most also demand the most aftercare and carry more ways to go wrong. A person with early damage and a target in the high teens is often well served by a gentler option. A person whose nerve is still deteriorating at a low pressure usually needs the more powerful procedure, accepting the closer follow-up that comes with it. Neither choice is better in the abstract; each is better for a particular eye.

Who is glaucoma surgery usually for, and who is asked to wait?

Surgeons think about candidates in terms of risk on both sides of the ledger: the risk of losing sight without surgery against the risk of harm from it.

Surgery is typically offered to people whose glaucoma is progressing despite maximal tolerated drops and laser, especially where the damage is moderate or advanced or affects the only well-seeing eye. It is also offered to those with pressures so high that no medicine combination can reasonably bring them down, to people with angle-closure that laser iridotomy has not fully resolved, and to those whose secondary glaucoma stems from a cause that a procedure can directly address. Someone with significant surface disease from years of preserved drops, or a person who cannot physically administer them, may be offered surgery earlier than the pressure numbers alone would suggest.

People are usually asked to wait when the disease is mild and stable, when pressure is only slightly above target and there are untried options, or when the trend is uncertain because only one or two reliable field tests exist. Field testing is noisy; a single bad result on a tired afternoon does not prove progression, and the NHS and Johns Hopkins both emphasize repeat monitoring before concluding that treatment has failed. Waiting is also common when other eye conditions, such as active inflammation or a recent retinal problem, would make surgery riskier right now, or when general health issues need to be stabilized first.

The Mayo Clinic adds a further reason for caution: surgery often needs to be repeated or supplemented later, because scarring and time erode any drainage pathway. Operating too early spends one of a limited number of surgical chances on an eye that did not yet need it. Waiting too long spends nerve fibers that never come back. The art lies in reading the trend well enough to land between those two mistakes, and that judgment belongs to the treating team who has watched the eye over time.

Glaucoma surgery with cataract surgery: doing two things at once

Glaucoma and cataract share the same decades of life, so many people face both. A cataract is a clouding of the eye’s natural lens, and removing it is one of the most frequently performed operations in medicine. That overlap has changed how glaucoma surgery is timed.

Cataract removal itself tends to lower eye pressure a little, because taking out the thickened lens opens up the drainage angle, particularly in eyes where the angle was narrow. For someone with mild glaucoma controlled on one drop, cataract surgery alone may be enough to hold the pressure steady, and the surgeon may not add anything else.

Where more reduction is wanted, the surgeon can add a MIGS procedure through the same tiny incision during the cataract operation. This is the setting where MIGS has found its widest use: the eye is already open, the extra time is short, and the goal is usually to reduce dependence on drops rather than to reach a very low target. The National Eye Institute describes MIGS as often being done at the same time as cataract surgery.

Combining cataract surgery with a trabeculectomy or tube is also possible but is a bigger decision. Cataract surgery stirs up inflammation that encourages scarring, and scarring is the enemy of a drainage bleb. Some surgeons therefore prefer to stage the operations, doing the glaucoma procedure first and the cataract later, or the reverse, depending on which problem is more pressing. Others combine them when a person cannot easily return for a second surgery.

The question to ask is simple: given my stage and target, would you address the pressure during my cataract operation, before it, or after it, and why? A clear answer to that question tells you a great deal about how your surgeon is weighing the trade-offs.

How serious is glaucoma eye surgery? Glaucoma surgery risks in plain language

People ask whether glaucoma surgery is serious, and the honest answer is that it sits in the middle of the range. It is not a trivial procedure, but it is not major surgery in the sense of a general anesthetic and a hospital stay. Most adults have it under local anesthetic and go home the same day. The seriousness lies less in the operation itself and more in the weeks of healing that follow, when the outcome is decided.

The risks described by the National Eye Institute, the NHS and the Mayo Clinic fall into a few groups. Pressure can end up too low rather than too high in the early weeks, which can cause blurred vision and, in some eyes, fluid or bleeding behind the retina until it settles. Pressure can rebound as the new pathway scars over, which is why so many follow-up visits are needed and why additional procedures are sometimes required. Infection is uncommon but potentially severe, and a drainage bleb carries a small lifetime risk of infection that never fully disappears, so any red, painful eye after a trabeculectomy needs same-day attention for the rest of a person’s life. Cataract tends to develop or progress faster after filtering surgery. Tubes can occasionally erode through the overlying tissue or affect the cornea over years. Vision can fluctuate for weeks, and a minority of people find their sight ends up a little worse than before.

Against these risks stands the alternative: continued nerve loss that no later treatment can reverse. That is why guidelines frame surgery as the option when non-surgical care is failing rather than as something to fear or to rush. Risk figures vary widely between studies, techniques and patient groups, and any single percentage would mislead more than it informs; your surgeon can quote the figures that apply to your specific operation and eye.

Glaucoma surgery recovery time: what the following days and weeks usually look like

Recovery from glaucoma surgery is less about pain and more about patience. Discomfort is usually mild and described as grittiness or aching, but vision is commonly blurred for days to weeks, and the eye is being actively managed the whole time.

The first day involves a protective shield and a follow-up visit, often within 24 hours, to check that the pressure is neither too high nor too low. After a trabeculectomy, the surgeon may loosen or remove adjustable stitches at subsequent visits to increase flow, or may massage the eye to keep the bleb open. Anti-inflammatory and antibiotic drops are prescribed for a period the surgeon sets; the National Eye Institute and NHS describe their use for several weeks, and the exact schedule is decided by the treating team. Previously used glaucoma drops are often paused in the operated eye and restarted only if pressure creeps up.

Activity restrictions are practical. Bending, heavy lifting, straining and rubbing the eye are discouraged in the early weeks because they raise pressure inside the eye and can disturb the new drainage site. Swimming and eye makeup are typically off the table until the surface has sealed. Driving depends on the vision in the other eye and how the operated eye is settling. The NHS notes that most people need a few weeks to recover, and many surgeons describe the bleb as continuing to remodel for two or three months.

MIGS recovery is shorter and closer to that of cataract surgery alone, usually measured in days rather than weeks, with fewer visits. Tube surgery sits between the two, with early pressure swings that need monitoring while the plate encapsulates.

Follow-up never truly ends. The Mayo Clinic is explicit that people need continued exams after surgery and may eventually need further procedures. Surgery changes the pressure; it does not end the disease, and lifelong monitoring remains the price of keeping sight.

What people often get wrong about glaucoma surgery

Myths gather around any operation on the eye, and several of them steer people toward bad decisions.

Surgery restores vision. It does not. Lost nerve fibers are gone, and the National Eye Institute states plainly that surgery cannot bring back vision already lost. The purpose is to protect the remaining field. People who go in expecting brighter, sharper sight are often disappointed, while people who understand the goal tend to judge the result fairly.

Surgery means you can throw away the drops. Sometimes, but not reliably. The Mayo Clinic notes that some people still need drops after surgery, and pressure can drift up over the years as the pathway scars.

Surgery is a last resort reserved for the desperate. Guidelines do not describe it that way. For advanced disease at diagnosis, for people who cannot use drops, and for certain angle-closure and secondary glaucomas, surgery is a reasonable early choice rather than a failure of everything else.

Once the pressure is normal, the glaucoma is gone. Glaucoma is a lifelong condition that is controlled, not eliminated. Pressure that reads normal today says nothing about next year without ongoing checks.

Newer always means better. MIGS devices have real advantages in safety and recovery, but they generally lower pressure less than trabeculectomy, and long-term data for some devices is still accumulating. For an eye that needs a very low target, the older operation may remain the right one.

Most people with glaucoma go blind. The disease is a leading cause of blindness worldwide, but that reflects undiagnosed and untreated eyes. With diagnosis and sustained treatment, the great majority of people keep useful vision for life. No single percentage applies to everyone, because outcomes depend on stage at diagnosis, how well pressure is controlled and how long a person lives with the disease.

Questions to ask your care team before deciding

The most useful appointment is the one where you arrive knowing what to ask. These questions help turn a recommendation into a shared plan.

• What stage is my glaucoma in each eye, and has it changed since my last visual field or OCT?
• What is my target pressure, and how did you arrive at it?
• Have we reached the practical limit of drops and laser for me, or are there options we have not tried?
• Which operation are you recommending, and why that one rather than the alternatives in the table above?
• How much pressure reduction do you expect, and what happens if it falls short or scars over?
• What are the specific risks for my eye, given my other eye conditions and general health?
• How many follow-up visits should I expect in the first three months, and can someone drive me?
• Will I still need drops afterward, in this eye or the other one?
• If I have a cataract too, should it be addressed at the same time, before, or later?
• What signs after surgery mean I should call you the same day?
• If I choose to wait, how will we know when waiting has stopped being safe?

Bring someone with you if you can. Eye appointments involve dilating drops that blur reading for hours, and a second pair of ears catches details you miss. Ask for the plan in writing, including your target pressure and the date of your next field test. A written target turns an abstract number into something you can track from visit to visit.

Finally, ask about the surgeon’s own approach: how often they perform the procedure being recommended and how they handle the follow-up period. This is not about ranking anyone. It is about understanding the pathway you are entering, because the weeks after surgery are as much a part of the treatment as the operation itself.

When to call your doctor: red-flag signs before and after glaucoma surgery

Glaucoma is usually a slow, quiet disease, which makes the exceptions stand out. Certain symptoms mean the pressure has changed suddenly, or that a complication is developing, and they need same-day contact with your eye clinic or an emergency department rather than a wait for the next scheduled visit.

Seek urgent care for a sudden onset of severe eye pain or a deep ache around one eye, especially with a headache, nausea or vomiting. The Mayo Clinic describes these, along with blurred vision, halos around lights and a red eye, as hallmarks of an acute angle-closure attack, in which pressure rises rapidly enough to damage the nerve within hours. Sudden loss or dimming of vision in either eye is also an emergency, whatever the suspected cause.

After any glaucoma operation, call the surgical team the same day if the eye becomes increasingly red, painful or light-sensitive, if vision drops noticeably compared with the previous day, if there is a sticky or pus-like discharge, or if you notice a new shadow or curtain across part of your sight. Anyone who has had a trabeculectomy should treat a red, painful eye as a potential bleb infection for life, even decades later, because that infection can spread inside the eye quickly. A gush of fluid, a sensation that the eye is unusually soft, or a sudden change in the appearance of the bleb also warrant a prompt call.

Between visits, do not wait for symptoms to guide you. Missed appointments are the commonest way glaucoma quietly advances. If you cannot attend a scheduled field test or pressure check, ask to be rebooked promptly rather than letting it slide. Contact the team, too, if you are struggling with drops, whether because of side effects or the sheer difficulty of using them; that is a clinical problem with clinical solutions, and telling your doctor is the first step toward one.

Frequently asked questions

Can you live with glaucoma without surgery?

Yes, many people manage glaucoma for life with drops, laser or both and never need an operation. Surgery becomes necessary only when those measures fail to hold pressure at the target, when the nerve keeps deteriorating anyway, or when drops cannot be tolerated or reliably used. Regular visual field and OCT monitoring is what tells the team which path a particular eye is on.

What percentage of glaucoma patients go completely blind?

There is no single reliable figure, because outcomes depend heavily on the stage at diagnosis, how consistently pressure is controlled and how long a person lives with the disease. Glaucoma is a leading cause of blindness worldwide, but that reflects mostly undiagnosed or untreated eyes. With detection and sustained treatment, most people keep useful vision for life, which is why guidelines stress lifelong monitoring.

How do you know what stage of glaucoma you have?

Your ophthalmologist stages glaucoma from three sources: the pattern and extent of visual field loss on perimetry, the thickness of the nerve fiber layer on an OCT scan, and the appearance of the optic nerve head. Stages are broadly described as mild, moderate or severe. Ask at each visit whether the stage has changed, since progression rather than the label itself drives decisions about surgery.

How serious is glaucoma eye surgery?

It is a moderate procedure: usually done under local anesthetic as a day case, with mild discomfort afterward, but followed by weeks of close monitoring that determine the result. The main risks include pressure that ends up too low or rebounds too high, scarring that closes the new drainage pathway, faster cataract development and, rarely, infection. Your surgeon can quote the risks specific to your operation and eye.

What is the difference between glaucoma laser vs surgery?

Laser trabeculoplasty is a clinic-based treatment that improves the eye’s natural drain without an incision; the Mayo Clinic notes its full effect can take a few weeks and it tends to wear off over time. Surgery creates a new drainage route through an incision, lowers pressure more and can be adjusted afterward, but requires more recovery and follow-up. Laser is usually tried before surgery unless disease is advanced.

What is the typical glaucoma surgery recovery time?

It depends on the operation. MIGS recovery is often measured in days, similar to cataract surgery. Trabeculectomy usually involves several weeks of blurred vision, frequent visits and activity restrictions, and the drainage bleb continues to settle for two to three months. The NHS describes a recovery of a few weeks for most people. The surgical team sets the drop schedule and tells you when normal activities can resume.

Will I still need eye drops after glaucoma surgery?

Possibly. The Mayo Clinic notes that some people still need glaucoma drops after surgery, either straight away if the pressure reduction falls short of target or years later as the new pathway gradually scars. Many people do reduce the number of bottles they use, and some stop entirely for a period. Only your treating team can decide whether and when any drop is paused or restarted.

Can glaucoma surgery be done at the same time as cataract surgery?

Yes. Cataract removal alone lowers pressure slightly, and a MIGS procedure can be added through the same small incision when more reduction is wanted. Combining cataract surgery with a trabeculectomy or tube is also possible but increases inflammation and scarring risk, so some surgeons prefer to stage the two operations. The right sequence depends on which problem is more urgent for your eye.

Does glaucoma surgery improve vision?

No. Its purpose is to lower eye pressure and slow or halt further optic nerve damage, not to sharpen sight. The National Eye Institute states that surgery cannot restore vision already lost. Vision is often blurrier for days or weeks after surgery before returning to roughly its previous level. People who understand this beforehand tend to judge the outcome more fairly than those expecting a visible improvement.

What happens if glaucoma surgery stops working?

Drainage pathways can scar over months or years, allowing pressure to rise again. The treating team may then restart drops, revise the original site, perform laser to the bleb, or offer a second procedure such as a tube or a laser that reduces fluid production. The Mayo Clinic notes that further procedures are sometimes needed after surgery, which is one reason lifelong follow-up visits continue.

References

• National Eye Institute (NIH): Glaucoma Surgery
• Cleveland Clinic: Glaucoma
• CDC: About Glaucoma

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.